Categories: Technology

AAX Biotech Supports the Fight Against Neurodegenerative Diseases with BioArctic’s Seqitope™

AAX Biotech, a Swedish biotech company specializing in innovative technologies for improving antibody-based medicines, is thrilled to announce that BioArctic AB, a renowned biopharma company focused on neurodegenerative diseases, has decided to utilize AAX Biotech’s proprietary epitope mapping technology, Seqitope™.

AAX Biotech is dedicated to addressing unmet demands in the advancement of next-generation antibody therapeutics. The company’s two pioneering technologies, Seqitope™ and Opti-mAb™, improve the performance and developability of antibody-based therapeutics and offer a unique solution in a rapidly growing market. This marks a significant milestone for AAX Biotech, highlighting the company’s role in advancing research with its Seqitope™ technology—a high-resolution, high-throughput method for antibody epitope mapping that accelerates the development of efficacious therapeutics.

“Having BioArctic use our technology represents a unique opportunity for AAX Biotech to contribute to the fight against neurodegenerative diseases which affect millions of persons worldwide,” says Maria L. Knudsen, CEO of AAX Biotech. “We are fully committed to this challenging project and are eager to apply our technology to support BioArctic.”

For more information about AAX Biotech or BioArctic AB please contact: Maria Lisa Knudsen, CEO +46 72 939 5018 maria.knudsen@aaxbiotech.com or [insert name] at [insert email address].

About AAX Biotech AB:

AAX Biotech AB is a biotech company specializing in next-generation antibody therapeutics. The company offers two unique and proprietary technologies, Seqitope™ and Opti-mAb™, that enable high throughput and high-resolution epitope mapping as well as stabilization of single chain variable fragments (scFv) for applications such as bispecific antibodies and CAR-T cells. Both technologies aim to produce better and more effective antibody-based medicines. These innovations position AAX Biotech as a key player in the rapidly growing antibody therapeutics market. Founded by experts from Karolinska Institutet in Stockholm, Sweden

Samantha Jones

As a content writer at newsnnk.com, I weave words into captivating stories that inform and engage our readers. With a passion for storytelling and an eye for detail, I strive to deliver high-quality and engaging content that resonates with our audience. From breaking news to thought-provoking features, I am dedicated to providing informative and compelling articles that keep our readers informed and entertained. Join me on this journey as we explore the world through the power of words.

Share
Published by
Samantha Jones

Recent Posts

The Cowboys Face Tough Decisions in Extending Star Players: Will Ceedee Lamb Follow Suit and Demand a New Contract?

With the Cowboys kicking off organized team activities, star players like Ezekiel Elliott and Zack…

23 mins ago

Erie County Athletes Shine in PIAA Playoffs: Softball Standouts Lead the Way

The Iroquois softball team recently celebrated a thrilling walk-off win in the playoffs, securing their…

27 mins ago

New Hyundai Sales and Service Center Opens in Roanoke County; Botetourt County Businesses Recognized for Community Contributions.

Southern Team Automotive Group recently opened a newly built Hyundai sales and service center in…

30 mins ago

Samsung Research and Arm Join Forces to Develop Parallel Packet Processing Technology for 6G Connectivity

Samsung Research and Arm have announced a partnership to develop parallel packet processing technology, which…

31 mins ago

Austin FC Parts Ways with DP Emiliano Rigoni After Missing Expectations: Report

On May 15, 2024, Emiliano Rigoni, the midfielder for Austin FC, was seen in command…

33 mins ago

Biden’s Tariffs Boost Domestic Solar Manufacturing in North Carolina, Despite Increase in EV Tariffs

The Biden administration has recently implemented tariffs on clean energy products as part of efforts…

34 mins ago